Noel S Wilson

USPTO Granted Patents = 12 (Patent Applications = 9)

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 11.2

ph-index = 3

Forward Citations = 34(Granted Patents)

Company Filing History:

Abbvie Deutschland Gmbh and Co Kg

patents

where one patent can have more than one assignee

Years Active: 2013-2019

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10280184 - Heterocyclic kinase inhibitors (2019-05-07),

2. 10273238 - Indazolones as modulators of TNF signaling (2019-04-30),

3. 10266532 - Tricyclic modulators of TNF signaling (2019-04-23),

4. 10160748 - Indazolones as modulators of tnf signaling (2018-12-25),

5. 9932340 - Substituted indoles (2018-04-03),

6. 9879033 - Modulators of 5-HT receptors and methods of use thereof (2018-01-30),

7. 9879016 - Indazolones as modulators of TNF signaling (2018-01-30),

8. 9856253 - Tricyclic modulators of TNF signaling (2018-01-02),

9. 9567339 - Primary carboxamides as BTK inhibitors (2017-02-14),

10. 9187483 - Modulators of 5-HT receptors and methods of use thereof (2015-11-17),

11. 8846951 - Modulators of 5-HT receptors and methods of use thereof (2014-09-30),

12. 8551981 - [object Object] (2013-10-08),

Title: The Innovative Contributions of Noel S. Wilson

Introduction

Noel S. Wilson is a prominent inventor based in Kenosha, Wisconsin, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, Wilson has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Wilson has developed heterocyclic kinase inhibitors. This invention provides compounds of Formula (I), including pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers, and isomers. These compounds are particularly useful for treating immunological and oncological conditions. Another notable patent involves indazolones as modulators of TNF signaling. Similar to his previous work, this disclosure also provides compounds of Formula (I) that are beneficial for treating immunological and oncological conditions.

Career Highlights

Throughout his career, Wilson has worked with esteemed companies such as AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Wilson has collaborated with notable colleagues, including Michael M. Friedman and Augustine Osuma. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

Noel S. Wilson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to advancing medical science. His work continues to pave the way for new treatments in immunology and oncology.

This text is generated by artificial intelligence and may not be accurate.